"Understanding Emotional Dysfunction, Heterogeneity, and Treatment Resp" by Stephanie SJ Morris
 

Document Type

Dissertation

Degree

Doctor of Philosophy (PhD)

Major/Program

Psychology

First Advisor's Name

Erica Musser

First Advisor's Committee Title

Committee chair

Second Advisor's Name

Joseph Raiker

Second Advisor's Committee Title

Committee member

Third Advisor's Name

Adela Timmons

Third Advisor's Committee Title

Committee member

Fourth Advisor's Name

Mariana Sanchez

Fourth Advisor's Committee Title

Committee member

Keywords

ADHD, EDA, emotion regulation, methylphenidate, RSA

Date of Defense

6-29-2022

Abstract

The objective of the current study is to identify the impact of methylphenidate (MPH) on autonomic functioning within an emotional context among youth with attention-deficit/hyperactivity disorder (ADHD; Aim 1a), consider for MPH dosage (Aim 1b), and heterogenous response to MPH using existing nosology (Aim 2). Further, the current study assesses autonomic functioning holistically to explain heterogenous behavioral disruptions (Aim 3). The current study utilizes psychophysiological and clinical data collected during a larger medication study. Results indicated that medication improved emotional functioning (indicated via psychophysiological indexes) among youth with ADHD to comparable levels as typically developing youth at the trait and state level. Further, youth with ADHD exhibit heterogenous autonomic functioning, which should be examined further for its utility to advance individualized treatment protocols.

Identifier

FIDC011098

Share

COinS
 

Rights Statement

Rights Statement

In Copyright. URI: http://rightsstatements.org/vocab/InC/1.0/
This Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s).